MDS 2022 | Genotype-based treatments for movement disorders

Marcelo Kauffman, MD, PhD, Hospital JM Ramos Mejia, Buenos Aires, Argentina, discusses future treatment strategies for hyperkinetic movement disorders. Advances in genetics and the increased availability of genetic testing will enable the growth of treatment approaches based on the patient’s genotype, thus ushering the era of precision medicine for movement disorders. This interview took place at the 2022 International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.